NEWRON PHARMACEUT. EO-20 (NP5) - Total Liabilities

Latest total liabilities as of June 2025: €59.81 Million EUR

Based on the latest financial reports, NEWRON PHARMACEUT. EO-20 (NP5) has total liabilities worth €59.81 Million EUR as of June 2025.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

NEWRON PHARMACEUT. EO-20 - Total Liabilities Trend (2005–2024)

This chart illustrates how NEWRON PHARMACEUT. EO-20's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

NEWRON PHARMACEUT. EO-20 Competitors by Total Liabilities

The table below lists competitors of NEWRON PHARMACEUT. EO-20 ranked by their total liabilities.

Liability Composition Analysis (2005–2024)

This chart breaks down NEWRON PHARMACEUT. EO-20's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how NEWRON PHARMACEUT. EO-20's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for NEWRON PHARMACEUT. EO-20 (2005–2024)

The table below shows the annual total liabilities of NEWRON PHARMACEUT. EO-20 from 2005 to 2024.